Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (1-10 of 308) with videos related to

Pageof 31
Sort By:
The New England Journal of Medicine|August 15, 2003
Clinical practice. Care of patients receiving long-term anticoagulant therapySam Schulman
Seminars in Thrombosis and Hemostasis|September 12, 2025
Recent Advances in Thrombosis and Hemostasis-Part XIISam Schulman
Seminars in Thrombosis and Hemostasis|January 20, 2004
Why is factor Xa not a better target than factor IIa for therapeutic inhibition of coagulation?Sam Schulman
Pathophysiology of Haemostasis and Thrombosis|April 7, 2005
The role of ximelagatran in the treatment of venous thromboembolismSam Schulman
Thrombosis and Haemostasis|September 10, 2016
Matching genes with constitution and environmentSam Schulman
ACP Journal Club|September 5, 2003
Low-intensity warfarin therapy prevented recurrent venous thromboembolismSam Schulman
Seminars in Thrombosis and Hemostasis|February 16, 2015
Treatment of venous thromboembolism with new oral anticoagulants according to patient riskSam Schulman
The Lancet. Haematology|August 1, 2020
Is venous thromboembolism a preventable cause of death?Sam Schulman
Seminars in Thrombosis and Hemostasis|November 2, 2019
Recent Advances in Thrombosis and Hemostasis-Part VSam Schulman
ACP Journal Club|July 2, 2005
Patient self-management of anticoagulants reduced arterial thromboembolism and adverse effectsSam Schulman
Pageof 31

Showing results (1-10 of 308) with videos related to

Sort By:
Pageof 31
The New England Journal of Medicine|August 15, 2003
Clinical practice. Care of patients receiving long-term anticoagulant therapySam Schulman
Seminars in Thrombosis and Hemostasis|September 12, 2025
Recent Advances in Thrombosis and Hemostasis-Part XIISam Schulman
Seminars in Thrombosis and Hemostasis|January 20, 2004
Why is factor Xa not a better target than factor IIa for therapeutic inhibition of coagulation?Sam Schulman
Pathophysiology of Haemostasis and Thrombosis|April 7, 2005
The role of ximelagatran in the treatment of venous thromboembolismSam Schulman
Thrombosis and Haemostasis|September 10, 2016
Matching genes with constitution and environmentSam Schulman
ACP Journal Club|September 5, 2003
Low-intensity warfarin therapy prevented recurrent venous thromboembolismSam Schulman
Seminars in Thrombosis and Hemostasis|February 16, 2015
Treatment of venous thromboembolism with new oral anticoagulants according to patient riskSam Schulman
The Lancet. Haematology|August 1, 2020
Is venous thromboembolism a preventable cause of death?Sam Schulman
Seminars in Thrombosis and Hemostasis|November 2, 2019
Recent Advances in Thrombosis and Hemostasis-Part VSam Schulman
ACP Journal Club|July 2, 2005
Patient self-management of anticoagulants reduced arterial thromboembolism and adverse effectsSam Schulman
Pageof 31